Market Cap 23.65B
Revenue (ttm) 3.81B
Net Income (ttm) -644.79M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 318.72
Profit Margin -16.92%
Debt to Equity Ratio 0.05
Volume 189,200
Avg Vol 468,388
Day's Range N/A - N/A
Shares Out 99.25M
Stochastic %K 82%
Beta 0.35
Analysts Strong Sell
Price Target $321.39

Company Profile

BeOne Medicines AG, an oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally. The company's commercial stage products include BRUKINSA, a small molecule inhibitor of Bruton's Tyrosine Kinase (BTK) for the treatment of various blood cancers; TEVIMBRA, an anti-PD-1 antibody immunotherapy for the treatment of various solid tumor and blood cancers; and PARTRUVIX, a selective small molecule inhibitor of...

Industry: Biotechnology
Sector: Healthcare
Phone: 41 61 685 19 00
Address:
Aeschengraben 27, 21st Floor, Basel, Switzerland
PrivateProfiteer
PrivateProfiteer Nov. 15 at 8:20 AM
$ONC Trade Plan: Market Context: $ONC is currently trading at $365.82, showing strong momentum but also elevated RSI at 70.81, indicating overbought conditions. The stock is above its 30-day moving average (MA30) of 326.85 and 50-day moving average (MA50) of 329.9, suggesting bullish sentiment. Directional Bias: The high of $381.5 in the last 60 days indicates potential resistance, while the low of $295.22 provides a strong support level. Given the current overbought RSI, a pullback may occur, but the overall trend remains bullish due to the price being above both MAs. Suggested Entry: Consider entering on a pullback to the MA30 around $326.85. Stop: Place a stop loss at $320 to manage risk. Targets: First target at $375, near recent highs, and a second target at $381.5, the 60-day high. Monitor price action closely for signs of reversal or continuation. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 14 at 11:41 PM
$ONC is currently trading at $365.82, showing a strong upward momentum as indicated by the RSI of 70.81, which suggests it is nearing overbought territory. The price is significantly above the 30-day moving average (MA30) of $326.85 and the 50-day moving average (MA50) of $329.9, indicating a bullish trend. However, the high of $381.5 over the last 60 days presents a potential resistance level. Given the current metrics, the directional bias is bullish, but caution is warranted due to the elevated RSI. Suggested entry could be around $360, allowing for a slight pullback. A stop loss should be set at $350 to manage risk. Target 1 can be set at $375, near the recent high, and Target 2 at $380, just below the 60D high. Monitor price action closely, as a reversal could occur given the RSI level. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 14 at 3:14 AM
$ONC is currently trading at $368.36, exhibiting a strong bullish momentum as indicated by an RSI of 73.37, which suggests it is overbought. The price is significantly above the 30-day MA of 326.12 and the 50-day MA of 329.42, reinforcing a bullish trend in the short term. However, the high of $381.25 within the last 60 days presents a resistance level that may be tested soon. Given the current metrics, the directional bias is bullish but caution is warranted due to the elevated RSI. A suggested entry point could be around $365, slightly below the current price to account for potential pullbacks. A stop loss should be set at $354, just below the 30-day MA, to manage risk. Targets can be set at $375, near the previous high, and $380, which is the 60-day high. This plan balances potential gains while managing the risks associated with the current overbought conditions. For further insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
_SquidGains_
_SquidGains_ Nov. 14 at 12:12 AM
0 · Reply
TrendEdgeLogan
TrendEdgeLogan Nov. 13 at 10:20 PM
I can still $SPOT several reasons that you $CNTA call $ONC 'le $INTA the $ASND 'ing seasonal tailwinds
0 · Reply
dj0ai
dj0ai Nov. 13 at 8:48 AM
$ONC Nah, it's hugely overvalued. The execs are seeing like crazy.
1 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 13 at 1:21 AM
$ONC Trade Plan: Market Context: The last close at $342.98 indicates a strong position within the recent trading range, with a 60-day high of $355.3 and a low of $295.22. The current RSI of 67.56 suggests that the stock is nearing overbought territory, which may lead to a pullback. Directional Bias: The stock is above both the 30-day MA (323.91) and the 50-day MA (327.59), indicating a bullish trend. However, the elevated RSI suggests caution, as it may signal a potential reversal or consolidation. Suggested Entry: Consider entering a long position on a pullback to the 30-day MA around $323.91 or a break above the recent high of $355.3. Stop: Set a stop loss at $330.00 to manage risk. Targets: Aim for a first target at $355.3 (60D high) and a second target at $365.00, which is a psychological level above the recent high. https://privateprofiteers.com
0 · Reply
albiegf13
albiegf13 Nov. 12 at 8:53 PM
0 · Reply
TrendEdgeLogan
TrendEdgeLogan Nov. 12 at 7:29 PM
They say there is nothing more bullish than a failed head-and-shoulders, so what does that mean for our friend $XBI? $300+ by the time the music goes out and the lights come on? Just keep dancing ​$CNTA $ONC $IBB
1 · Reply
Pika_Capital
Pika_Capital Nov. 12 at 6:23 PM
$ONC time to clear all time highs
0 · Reply
Latest News on ONC
BeOne Medicines AG (ONC) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 3:16 PM EST - 8 days ago

BeOne Medicines AG (ONC) Q3 2025 Earnings Call Transcript


BeOne Medicines to Present at Upcoming Investor Conferences

Oct 28, 2025, 6:01 AM EDT - 18 days ago

BeOne Medicines to Present at Upcoming Investor Conferences


BeOne Medicines Ltd. (ONC) Q2 2025 Earnings Call Transcript

Aug 6, 2025, 1:36 PM EDT - 3 months ago

BeOne Medicines Ltd. (ONC) Q2 2025 Earnings Call Transcript


BeiGene, Ltd. (ONC) Q1 2025 Earnings Call Transcript

May 7, 2025, 2:04 PM EDT - 6 months ago

BeiGene, Ltd. (ONC) Q1 2025 Earnings Call Transcript


PrivateProfiteer
PrivateProfiteer Nov. 15 at 8:20 AM
$ONC Trade Plan: Market Context: $ONC is currently trading at $365.82, showing strong momentum but also elevated RSI at 70.81, indicating overbought conditions. The stock is above its 30-day moving average (MA30) of 326.85 and 50-day moving average (MA50) of 329.9, suggesting bullish sentiment. Directional Bias: The high of $381.5 in the last 60 days indicates potential resistance, while the low of $295.22 provides a strong support level. Given the current overbought RSI, a pullback may occur, but the overall trend remains bullish due to the price being above both MAs. Suggested Entry: Consider entering on a pullback to the MA30 around $326.85. Stop: Place a stop loss at $320 to manage risk. Targets: First target at $375, near recent highs, and a second target at $381.5, the 60-day high. Monitor price action closely for signs of reversal or continuation. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 14 at 11:41 PM
$ONC is currently trading at $365.82, showing a strong upward momentum as indicated by the RSI of 70.81, which suggests it is nearing overbought territory. The price is significantly above the 30-day moving average (MA30) of $326.85 and the 50-day moving average (MA50) of $329.9, indicating a bullish trend. However, the high of $381.5 over the last 60 days presents a potential resistance level. Given the current metrics, the directional bias is bullish, but caution is warranted due to the elevated RSI. Suggested entry could be around $360, allowing for a slight pullback. A stop loss should be set at $350 to manage risk. Target 1 can be set at $375, near the recent high, and Target 2 at $380, just below the 60D high. Monitor price action closely, as a reversal could occur given the RSI level. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 14 at 3:14 AM
$ONC is currently trading at $368.36, exhibiting a strong bullish momentum as indicated by an RSI of 73.37, which suggests it is overbought. The price is significantly above the 30-day MA of 326.12 and the 50-day MA of 329.42, reinforcing a bullish trend in the short term. However, the high of $381.25 within the last 60 days presents a resistance level that may be tested soon. Given the current metrics, the directional bias is bullish but caution is warranted due to the elevated RSI. A suggested entry point could be around $365, slightly below the current price to account for potential pullbacks. A stop loss should be set at $354, just below the 30-day MA, to manage risk. Targets can be set at $375, near the previous high, and $380, which is the 60-day high. This plan balances potential gains while managing the risks associated with the current overbought conditions. For further insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
_SquidGains_
_SquidGains_ Nov. 14 at 12:12 AM
0 · Reply
TrendEdgeLogan
TrendEdgeLogan Nov. 13 at 10:20 PM
I can still $SPOT several reasons that you $CNTA call $ONC 'le $INTA the $ASND 'ing seasonal tailwinds
0 · Reply
dj0ai
dj0ai Nov. 13 at 8:48 AM
$ONC Nah, it's hugely overvalued. The execs are seeing like crazy.
1 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 13 at 1:21 AM
$ONC Trade Plan: Market Context: The last close at $342.98 indicates a strong position within the recent trading range, with a 60-day high of $355.3 and a low of $295.22. The current RSI of 67.56 suggests that the stock is nearing overbought territory, which may lead to a pullback. Directional Bias: The stock is above both the 30-day MA (323.91) and the 50-day MA (327.59), indicating a bullish trend. However, the elevated RSI suggests caution, as it may signal a potential reversal or consolidation. Suggested Entry: Consider entering a long position on a pullback to the 30-day MA around $323.91 or a break above the recent high of $355.3. Stop: Set a stop loss at $330.00 to manage risk. Targets: Aim for a first target at $355.3 (60D high) and a second target at $365.00, which is a psychological level above the recent high. https://privateprofiteers.com
0 · Reply
albiegf13
albiegf13 Nov. 12 at 8:53 PM
0 · Reply
TrendEdgeLogan
TrendEdgeLogan Nov. 12 at 7:29 PM
They say there is nothing more bullish than a failed head-and-shoulders, so what does that mean for our friend $XBI? $300+ by the time the music goes out and the lights come on? Just keep dancing ​$CNTA $ONC $IBB
1 · Reply
Pika_Capital
Pika_Capital Nov. 12 at 6:23 PM
$ONC time to clear all time highs
0 · Reply
TrendEdgeLogan
TrendEdgeLogan Nov. 12 at 3:21 PM
$ONC patience pays 📈
0 · Reply
MaverikIT
MaverikIT Nov. 12 at 3:08 PM
$ONC +18.71 - knocking on door #52wk$ again
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 12 at 12:57 AM
$ONC Trade Plan: Market Context: The last close at $342.98 indicates a strong position within the recent trading range, with a 60-day high of $355.3 and a low of $295.22. The current RSI of 67.56 suggests that the stock is nearing overbought territory, which may lead to a pullback. Directional Bias: The stock is above both the 30-day MA (323.91) and the 50-day MA (327.59), indicating a bullish trend. However, the elevated RSI suggests caution, as it may signal a potential reversal or consolidation. Suggested Entry: Consider entering a long position on a pullback to the 30-day MA around $323.91 or a break above the recent high of $355.3. Stop: Set a stop loss at $330.00 to manage risk. Targets: Aim for a first target at $355.3 (60D high) and a second target at $365.00, which is a psychological level above the recent high. https://privateprofiteers.com
0 · Reply
MaverikIT
MaverikIT Nov. 11 at 10:09 PM
$QURE +4.85 - nice recovery for now $PRAX $ONC $CDTX ...
0 · Reply
JarvisFlow
JarvisFlow Nov. 10 at 9:31 PM
Citigroup updates rating for BeOne Medicines ( $ONC ) to Buy, target set at 399 → 405.
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 9 at 10:43 PM
0 · Reply
TheHookingBull
TheHookingBull Nov. 8 at 2:54 PM
$ONC ridiculous price drop after earnings. Plus a 1 share sell trade after hours dropped this -$5+ 🙄
0 · Reply
albiegf13
albiegf13 Nov. 8 at 12:29 AM
1 · Reply
JarvisFlow
JarvisFlow Nov. 7 at 6:17 PM
RBC Capital updates rating for BeOne Medicines ( $ONC ) to Outperform, target set at 374 → 395.
0 · Reply
JarvisFlow
JarvisFlow Nov. 7 at 1:58 PM
Citizens has updated their rating for BeOne Medicines ( $ONC ) to Market Outperform with a price target of 396.
0 · Reply
TheHookingBull
TheHookingBull Nov. 6 at 8:22 PM
$ONC price target upgrades tomorrow
0 · Reply
d_risk
d_risk Nov. 6 at 4:34 PM
$ONC - BeiGene, Ltd. - 10Q - Updated Risk Factors ONC’s 10-Q risk factors now span regulatory, financial, patent, and operational risks, with expanded focus on commercialization challenges, intense competition, global pricing pressures, China-related regulatory and geopolitical threats, delisting risk, share volatility, triple listing complexities, insider control, and new Swiss legal and tax exposures post-jurisdictional move. #Pharmaceuticals #MarketVolatility #GeopoliticalRisks #CommercializationChallenges #RegulatoryRisks 🟢 Added 🟠 Removed https://d-risk.ai/ONC/10-Q/2025-11-06
0 · Reply